Schedule 13G ownership disclosure

CASI PHARMACEUTICALS INC

Security class unavailable · CUSIP: 14757U109

Event date: 2019-12-30

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.9100%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-022801
Form type
SC 13G/A
Filer
CASI Pharmaceuticals, Inc (DE)
CIK
CIK 895051
Filed
Feb 19, 2020
Reporting period
Dec 30, 2019
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub